What's breaking now, across thousands of outlets.
For most biopharmas, guiding to flat growth for the year would be a disappointment. For Novo, it’s an upgrade. The drugmaker said Wednesday that its 2026 sales would be between 2% ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Travelers must attest they have not been in the DRC in the past 21 days, with the order set to remain in effect until December 18.
The report highlighted that while healthcare cost growth is slowing, it remains well above India's projected inflation rate of 4 per cent.
“I also want to preserve the opportunity to leave a meaningful legacy for my two sons.”
Investment announced at first Global Summit for Eye Health
Gaza volunteer surgeon Adam Hamawy wins US House seat in New Jersey Democrat Adam Hamawy, who treated Palestinians in Gaza during Israel’s genocide, has defeated Republican Gregg Mele to represent New…
Innovation in Switzerland’s pharmaceutical industry has fallen for the second year in a row, a new study shows, underscoring how it is trailing foreign competitors in digital research and clinical…
